Evidence map›Paper›PMID 32448290›Full record

ReviewHarm reduction journal2020

Prisoners should not be left behind in HCV research and policies.

Babak Moazen, Heino Stöver, Kate Dolan, Albrecht Jahn, Florian Neuhann

Abstract readReview
In one paragraph

Review in Harm reduction journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Babak MoazenHeidelberg Institute of Global Health, Heidelberg University, Bergheimer Str. 20, Zimmer 317, 69115, Heidelberg, Germany. babak.moazen@uni-heidelberg.de.ORCID 0000-0002-2552-0438
Heino StöverDepartment of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
Kate DolanProgram of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Albrecht JahnHeidelberg Institute of Global Health, Heidelberg University, Bergheimer Str. 20, Zimmer 317, 69115, Heidelberg, Germany.
Florian NeuhannHeidelberg Institute of Global Health, Heidelberg University, Bergheimer Str. 20, Zimmer 317, 69115, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With a worldwide prevalence of 15.4%, hepatitis C virus (HCV) has been estimated to be the most prevalent major infectious disease in prisons. The exceptionally high prevalence of HCV in prisons is attributable to common risk behaviors including sharing contaminated tattooing equipment and drug paraphernalia, as well as lack of HCV control interventions including needle and syringe programs. Despite the importance of attention to prisoners as a highly at-risk population to acquire and transmit HCV, the number of HCV research and policy documents ignoring prisoners is increasing. Highlighting this issue, the present manuscript discusses how excluding prisoners from HCV-related research and policies will jeopardize the global HCV elimination goals set forth by the global community.

Indexed as

Health PolicyResearchHepatitis CHumansPrisonersRisk FactorsRisk-TakingSubstance Abuse, IntravenousTattooing

Identifiers

PMID32448290
PMCPMC7245876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.